advanced search
Claus Schmidt Moeller
Chief Technology Officer and Founder

Is this your profile?

About

Claus Schmidt Moeller, Founder of Subcuject and inventor of the Subcuject device concept, has 25 years’ experience in innovation of drug delivery devices.

He is the inventor of the mechanical concept of Novo Nordisk’s Novopen 4, 5 and 6, and co-inventor of the company’s Flexpen and Flextouch insulin pens. Additionally, he has developed and licensed several injection device concepts for major pharma and device companies, and is named as inventor or co-inventor on more than 60 patent families.

Mr Moeller holds a BSc in Mechanical Engineering.

Contributions

WEARABLES
SUBCUJECT WBI: LOW-COST, LARGER VOLUME, HIGH-VISCOSITY WEARABLE BOLUS INJECTOR – USING STANDARD GLASS PRIMARY PACKAGING
Claus Schmidt Moeller introduces the company’s wearable bolus injector for single use and discusses the advantages of the device.

More contributions

WEARABLES
APPLICATION OF CFD IN THE DEVELOPMENT OF A WEARABLE BOLUS INJECTOR
Marcus Hall, Björn Ullbrand and Claus Schmidt Møller describe the use of computational fluid dynamics (CFD) as the primary design and analysis tool in the development of a wearable bolus injector.
WEARABLES
DEVELOPMENT OF AN OSMOTIC LARGER VOLUME WEARABLE BOLUS INJECTOR
Claus Schmidt Moeller provides an overview of the mechanism, functionality and applications of the company’s osmotic, single-use, low-cost, versatile wearable bolus injector.
Top